The video interview below features Marc Tessier-Lavigne, Executive Vice President of Research and Chief Scientific Officer, discussing the findings that have been published in a paper appearing in Nature. The findings suggest a new approach to treating Alzheimer's disease.

Read the transcript of the interview.